The cholesterol ester transfer protein inhibitor, anacetrapib (vol 22, pg 245, 2011)

被引：0
|
作者：
Jialal, I
Kaur, J.
机构：
来源：
CURRENT OPINION IN LIPIDOLOGY | 2011年 / 22卷 / 04期
关键词：
D O I：
10.1097/MOL.0b013e328348b6e5
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：326 / 326
页数：1
相关论文
共 50 条
  • [1] The cholesterol ester transfer protein inhibitor, anacetrapib
    Jialal, Ishwarlal
    Kaur, Jaspreet
    CURRENT OPINION IN LIPIDOLOGY, 2011, 22 (03) : 245 - 246
  • [2] Anacetrapib, a cholesterol ester transfer protein (CETP) inhibitor for treatment of atherosclerosis
    Masson, David
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (09) : 980 - 987
  • [3] Anacetrapib, a cholesteryl ester transfer protein inhibitor
    Hooper, Amanda J.
    Burnett, John R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (01) : 103 - 109
  • [4] EFFECTS OF THE CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR ANACETRAPIB ON LIPOPROTEIN SUBFRACTIONS
    Krauss, R.
    Wojnoonski, K.
    Geaney, J. C.
    Kimberlin, R.
    Johnson-Levonas, A.
    Luk, J.
    Krishna, R.
    Wagner, J.
    Anderson, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [5] Metabolism and Excretion of Anacetrapib, a Novel Inhibitor of the Cholesteryl Ester Transfer Protein, in Humans
    Kumar, Sanjeev
    Tan, Eugene Y.
    Hartmann, Georgy
    Biddle, Zachary
    Bergman, Arthur J.
    Dru, James
    Ho, Jonathan Z.
    Jones, Allen N.
    Staskiewicz, Steve J.
    Braun, Matthew P.
    Karanam, Bindhu
    Dean, Dennis C.
    Gendrano, Isaias Noel
    Graves, Mark W.
    Wagner, John A.
    Krishna, Rajesh
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (03) : 474 - 483
  • [6] MEDI 263-Discovery of the cholesteryl ester transfer protein inhibitor anacetrapib
    Sinclair, Peter J.
    Ali, Amjad
    Lu, Zhijian
    Smith, Cameron
    Thompson, Christopher F.
    Taylor, Gayle
    Anderson, Matt S.
    Eveland, Suzanne S.
    Hyland, Sheryl A.
    Latham, Melanie J.
    Tong, Xinchun
    Xu, Suoyu S.
    Peterson, Laurence B.
    Rosa, Ray
    Sparrow, Carl P.
    Hammond, Milton L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [7] Model-Based Development of Anacetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor
    Rajesh Krishna
    Arthur J. Bergman
    Michele Green
    Marissa F. Dockendorf
    John A. Wagner
    Kevin Dykstra
    The AAPS Journal, 2011, 13 : 179 - 190
  • [8] Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia
    Teramoto, Tamio
    Shirakawa, Masayoshi
    Kikuchi, Masashi
    Nakagomi, Mariko
    Tamura, Satoko
    Surks, Howard K.
    Sisk, Christine McCrary
    Numaguchi, Hirotaka
    ATHEROSCLEROSIS, 2013, 230 (01) : 52 - 60
  • [9] Model-Based Development of Anacetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor
    Krishna, Rajesh
    Bergman, Arthur J.
    Green, Michele
    Dockendorf, Marissa F.
    Wagner, John A.
    Dykstra, Kevin
    AAPS JOURNAL, 2011, 13 (02): : 179 - 190
  • [10] Antisense Inhibition of Cholesteryl Ester Transfer Protein Increases HDL Cholesterol Comparable to Anacetrapib in Transgenic Mice
    Bell, Thomas A.
    Graham, Mark
    Lee, Richard
    Mullick, Adam
    Fu, Wuxia
    Crooke, Rosanne
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E212 - E212
12345